Generics - Antibiotics and Infectious diseases, Regulation


Popular Filters

South Africa regulator gives MSF access to cheaper TB drug linezolid

South Africa regulator gives MSF access to cheaper TB drug linezolid


After a three-year long struggle, humanitarian aid agency Medecins Sans Frontieres has received approval…

Antibiotics and Infectious diseasesGenericsHealthcareLinezolidPfizerRegulationSouth AfricaZyvox

Recipharm files for European approval of first-in class generic anti-infective


Swedish contract development and manufacturing group Recipharm says its subsidiary RPH Pharmaceuticals…

Antibiotics and Infectious diseasesAstimex PharmaEuropeGenericsRecipharmRegulationRPH Pharmaceuticals

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI


Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

US FDA pulls 27 Ranbaxy ANDAs approvals under consent decree


The Food and Drug Administration is withdrawing approval of 27 Abbreviated New Drug Applications (ANDAs)…

Antibiotics and Infectious diseasesDaiichi SankyoDiabetesGenericsNorth AmericaRanbaxy LaboratoriesRegulation

UK's NICE launches new medicines advisory service


The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) last Friday launched…

Antibiotics and Infectious diseasesAstellas PharmaBiotechnologyDificlirEuropeGenericsPharmaceuticalRegulation

ViroPharma stock plunges on bad news for Vancocin; Sanofi patents invalidated


ViroPharma I (Nasdaq: VPHM) saw its shares plunge 19% to $23.25 yesterday after it announced that the…

Antibiotics and Infectious diseasesApotexGenericsHospiraLegalNorth AmericaOncologyPatentsPharmaceuticalRegulationSanofiTaxotereVancocinViroPharmaWatson Pharmaceuticals

Back to top